Their work focused on the tumour promoter role of TGFβ, finding that its RAC1B-dependent inhibition leads to a suppression of cell proliferation and migration in different PAAD and malignant breast cell lines [37]. This evidence concerns the gene TGFB1 and pancreatic adenocarcinoma.